Drug-drug interactions of icenticaftor (QBW251) with a 5-probe cytochrome P450 cocktail and oral contraceptives.
Saved in:
| Title: | Drug-drug interactions of icenticaftor (QBW251) with a 5-probe cytochrome P450 cocktail and oral contraceptives. |
|---|---|
| Authors: | Huth F; Novartis Pharma AG, Basel, Switzerland., Glaenzel U; Novartis Pharma AG, Basel, Switzerland., Drollmann A; Novartis Pharma AG, Basel, Switzerland., Weis W; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA., Zack J; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA., Bebrevska L; Novartis Pharma AG, Basel, Switzerland. |
| Source: | Clinical and translational science [Clin Transl Sci] 2024 Sep; Vol. 17 (9), pp. e70028. |
| Publication Type: | Journal Article; Randomized Controlled Trial |
| Journal Info: | Publisher: WileyBlackwell Pub Country of Publication: United States NLM ID: 101474067 Publication Model: Print Cited Medium: Internet ISSN: 1752-8062 (Electronic) Linking ISSN: 17528054 NLM ISO Abbreviation: Clin Transl Sci Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1752-8062 |
|---|---|
| DOI: | 10.1111/cts.70028 |
